Do you know what your patients are saying about you? Your online reputation depends on whether and/or how you react to what people say about your services. Today, according to the ADA Center for Professional Success, many patients investigate your office prior to an initial appointment using Google, Yelp, and many other review and research sources. Make sure… Read More »
Marketing your dental practice is key to attracting new patients but it’s also important to do so ethically and to follow the law. “The key is to be informed,” said Dr. Kevin Sessa, chair of the ADA Council on Dental Practice. “When you know the rules, you are better equipped to avoid breaking them. As dentists and small… Read More »
The latest issue of the New Dentist News is now available online. The October 2014 issue includes articles to help new dentists with marketing, finances and handling ethical dilemmas. Inside this issue include: Marketing snapshot — How one practice does it. Marketing the dental practice: Know the rules. Working with a marketing firm. Advice from a lender: Be… Read More »
Avoid hot water when it comes to sticky practice situations with the ADA Ethics Hotline, a member benefit made possible by a joint effort between The Council on Ethics, Bylaws and Judicial Affairs (CEBJA), the New Dentist Committee and the ADA Member Service Center. Though a ready asset for any ADA member, new dentists in particular may… Read More »
The American Dental Association Council on Scientific Affairs is extending the application deadline for the 2014 John W. Stanford New Investigator Award to Oct. 31. Applications for the Stanford New Investigator Award are accepted annually from dental students or dentists who have earned their D.D.S. or D.M.D. degrees no more than five years prior to the time of… Read More »
The Drug Enforcement Administration is reclassifying hydrocodone combination products and subjecting them to tighter restrictions. Hydrocodone combination products, which include opioids such as Vicodin, Lorcet, Lortab and Norco, will be reclassified as Schedule II substances, effective Oct. 6. The DEA says the reclassification will protect public health and safety by reducing the potential for abuse, dependence and diversion… Read More »